Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728260 · ClinicalTrials.gov registry record
36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 1,421
- Enrollment target
NCT00728260 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 1,421 participants.
The verdict
NCT00728260 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 1,421 participants
- Enrollment target
Study Summary
To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
Interventions
- BIOLOGICAL None administered in this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,421 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728260
The ClinicalTrials.gov registry entry for NCT00728260 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,421 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which None administered in this study is the first listed.
NCT00728260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00728260 about?
NCT00728260 is a clinical study titled "36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds". To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
What is the current status of trial NCT00728260?
This trial is currently completed. The enrollment target is 1,421 participants. The study started on 2005-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00728260?
The interventions under investigation include: None administered in this study (BIOLOGICAL).
Who is sponsoring clinical trial NCT00728260?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.